Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 29968
Gene Symbol: PSAT1
PSAT1
0.020 GeneticVariation phenotype BEFREE Logistic regression analysis showed that greater neighborhood cohesion was associated with higher likelihood of utilizing a mammogram (OR 1.32, 95% CI 1.14-1.52), a Pap test (OR 1.22, 95% CI 1.06-1.41), but not of a blood stool test (OR 1.10, 95% CI 0.98-1.23), a colonoscopy (OR 1.05, 95% CI 0.94-1.17), and a PSA test (OR 1.13, 95% CI 0.95-1.34). 29980880 2019
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.020 GeneticVariation phenotype BEFREE Logistic regression analysis showed that greater neighborhood cohesion was associated with higher likelihood of utilizing a mammogram (OR 1.32, 95% CI 1.14-1.52), a Pap test (OR 1.22, 95% CI 1.06-1.41), but not of a blood stool test (OR 1.10, 95% CI 0.98-1.23), a colonoscopy (OR 1.05, 95% CI 0.94-1.17), and a PSA test (OR 1.13, 95% CI 0.95-1.34). 29980880 2019
Entrez Id: 5324
Gene Symbol: PLAG1
PLAG1
0.020 Biomarker phenotype BEFREE Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. 30733308 2019
Entrez Id: 29968
Gene Symbol: PSAT1
PSAT1
0.020 Biomarker phenotype BEFREE Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. 30733308 2019
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.020 Biomarker phenotype BEFREE Chronically stimulated rats, compared to unstimulated rats, had improved stool quality (two-way RM ANOVA: <i>P</i> < 0.0001), no blood in feces (<i>P</i> < 0.0001), reduced plasma C-reactive protein (two-way RM ANOVA: <i>P</i> < 0.05) and a reduction in resident inflammatory cell populations within the intestine (Kruskal-Wallis: <i>P</i> < 0.05). 31133776 2019
Entrez Id: 5324
Gene Symbol: PLAG1
PLAG1
0.020 GeneticVariation phenotype BEFREE Logistic regression analysis showed that greater neighborhood cohesion was associated with higher likelihood of utilizing a mammogram (OR 1.32, 95% CI 1.14-1.52), a Pap test (OR 1.22, 95% CI 1.06-1.41), but not of a blood stool test (OR 1.10, 95% CI 0.98-1.23), a colonoscopy (OR 1.05, 95% CI 0.94-1.17), and a PSA test (OR 1.13, 95% CI 0.95-1.34). 29980880 2019
Entrez Id: 9520
Gene Symbol: NPEPPS
NPEPPS
0.020 GeneticVariation phenotype BEFREE Logistic regression analysis showed that greater neighborhood cohesion was associated with higher likelihood of utilizing a mammogram (OR 1.32, 95% CI 1.14-1.52), a Pap test (OR 1.22, 95% CI 1.06-1.41), but not of a blood stool test (OR 1.10, 95% CI 0.98-1.23), a colonoscopy (OR 1.05, 95% CI 0.94-1.17), and a PSA test (OR 1.13, 95% CI 0.95-1.34). 29980880 2019
Entrez Id: 5627
Gene Symbol: PROS1
PROS1
0.020 Biomarker phenotype BEFREE Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. 30733308 2019
Entrez Id: 9520
Gene Symbol: NPEPPS
NPEPPS
0.020 Biomarker phenotype BEFREE Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. 30733308 2019
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.020 Biomarker phenotype BEFREE Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. 30733308 2019
Entrez Id: 5627
Gene Symbol: PROS1
PROS1
0.020 GeneticVariation phenotype BEFREE Logistic regression analysis showed that greater neighborhood cohesion was associated with higher likelihood of utilizing a mammogram (OR 1.32, 95% CI 1.14-1.52), a Pap test (OR 1.22, 95% CI 1.06-1.41), but not of a blood stool test (OR 1.10, 95% CI 0.98-1.23), a colonoscopy (OR 1.05, 95% CI 0.94-1.17), and a PSA test (OR 1.13, 95% CI 0.95-1.34). 29980880 2019
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.020 Biomarker phenotype BEFREE Multiple regression showed that empiric antimicrobial therapy (p = 0.017), advanced age (p = 0.003), hematochezia (p = 0.008), elevated serum creatinine (p < 0.001), and elevated serum C-reactive protein (p = 0.002) were significant risk factors of longer hospitalization duration. 28986192 2018
Entrez Id: 4146
Gene Symbol: MATN1
MATN1
0.010 Biomarker phenotype BEFREE Primary outcomes were resolution of hematochezia and acquisition of tolerance to CMP at 6, 12, 24, and 36 months. 31230196 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.010 Biomarker phenotype BEFREE Herbaceous plants and their extracts have been shown to be effective against IBD in many studies, and herbaceous plants may be effective in treating symptoms such as abdominal pain, diarrhea, mucus, and bloody stools. 31504527 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 AlteredExpression phenotype BEFREE Furthermore, the treatment also significantly increased SOD levels, decreased MDA, TNF-α, and IL-6 levels (P < .05).Acute-onset abdominal cramping or abdominal pain followed with hematochezia was the mainly initial symptom of IC, and sigmoid and descending colons were the common vulnerable sites. 30170462 2018
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 AlteredExpression phenotype BEFREE Furthermore, the treatment also significantly increased SOD levels, decreased MDA, TNF-α, and IL-6 levels (P < .05).Acute-onset abdominal cramping or abdominal pain followed with hematochezia was the mainly initial symptom of IC, and sigmoid and descending colons were the common vulnerable sites. 30170462 2018
Entrez Id: 7454
Gene Symbol: WAS
WAS
0.010 GeneticVariation phenotype BEFREE Non-haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3-8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation. 23023736 2013
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 GeneticVariation phenotype BEFREE From these, K-ras mutations detected in blood, stool and bile juice of patients at risk for pancreatic cancer seem to be more promising than p53 alterations as a more later step in carcinogenesis, although they are neither yet well established nor standardised by reliable assays. 10436809 1999
Entrez Id: 324
Gene Symbol: APC
APC
0.010 GeneticVariation phenotype BEFREE Familial adenomatous polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC), as well as early stages of spontaneous CRC, can be diagnosed by molecular characterisation of the adenomatous polyposis coli (APC) gene, the RAS oncogene and other genes in DNA from peripheral blood, stool or intestinal biopsies. 7577053 1995